AstraZeneca, the renowned pharmaceutical giant, has unveiled plans to invest $1.5 billion in a cutting-edge antibody drug conjugate (ADC) manufacturing facility in Singapore, marking a significant milestone in the company's history. The state-of-the-art factory is poised to become operational in
Solvias' announcement of opening a new biotech facility in Research Triangle Park, North Carolina, has sparked excitement and anticipation within the Raleigh-Durham area. The region, already renowned for its concentration of tech and biotech firms, is poised to add another jewel to its crown with
ChargePoint Technology is taking a significant leap to scale up its manufacturing capabilities amid surging demand for single-use disposable systems in the pharmaceutical sector. By pouring investment into a state-of-the-art facility in Speke, Liverpool, the company aims to strengthen its position
In a groundbreaking initiative, Moderna has joined forces with AI powerhouse OpenAI to revolutionize vaccine development through artificial intelligence. This move signifies a fusion of Moderna's medical prowess with OpenAI's advanced AI technology. Together, they seek to transform the way vaccines
BioNTech, the German biotechnology company known for its pivotal role in creating a COVID-19 vaccine with Pfizer, has inaugurated a state-of-the-art modular mRNA vaccine production facility in Kigali, the capital of Rwanda. This initiative marks a significant step toward health equality and local
Eli Lilly is making a significant move to fortify its global network for manufacturing parenteral products by acquiring a facility from Nexus Pharmaceuticals. This strategic step is set to greatly enhance Lilly's ability to supply its growing number of medications and underscores a commitment to
